MedTrace Logo

Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates

NCT05717842 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2026-03-12

No results posted yet for this study

Summary

The purpose of the study is to determine how much a persons kidney function recovers after receiving a simultaneous liver kidney transplant. The investigators will be contacting patients with kidney dysfunction with estimated GFR between 25 and 40 (not on dialysis treatment) who are listed to receive a simultaneous liver kidney (SLK) transplant to look at this function recovery. The investigators hope to develop a criteria based on GFR measurement, kidney function calculations from native kidneys vs transplanted kidney and compare the contributions, and correlate with estimated GFR on basic metabolic panel (BMP: a blood test) to predict higher chances of recovery of native kidney function.

Conditions

  • Transplant

Interventions

RADIATION

Nuclear Medicine Scan

Mercaptoacetyltriglycine 3 (Mag 3) Nuclear Medicine Scan

Sponsors & Collaborators

  • Jerome A. Josephs Fund for Transplant Innovation Fund

    collaborator UNKNOWN

  • Indiana University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-08
Primary Completion
2026-12-31
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05717842 on ClinicalTrials.gov